Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    symbols : Anix    save search

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -1.23% H: 2.18% C: 0.62%

vaccine congress world presentation
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Published: 2024-01-23 (Crawled : 13:30) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.09% C: 1.03%

patent vaccine cancer technology
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06 (Crawled : 23:00) - prnewswire.com
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 2.29% H: 5.63% C: -10.45%

vaccine breast positive cancer study
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06 (Crawled : 21:00) - prnewswire.com
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 2.29% H: 5.63% C: -10.45%

conference vaccine breast positive cancer ongoing study
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Published: 2023-11-27 (Crawled : 13:30) - prnewswire.com
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 8.47% C: 5.08%

patent vaccine cancer technology
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Published: 2023-10-03 (Crawled : 13:30) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 4.64% H: 0.95% C: -3.48%

patent vaccine cancer technology
Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial
Published: 2023-08-07 (Crawled : 14:00) - biospace.com/
MRK | $127.0 0.1% 0.63% 5.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.28% H: 0.94% C: 0.76%
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.66% C: -4.27%

keytruda arm vaccine breast cancer ongoing trial
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 2.25% H: 2.2% C: -2.2%

patent vaccine cancer technology
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Published: 2023-04-17 (Crawled : 23:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 1.84% H: 6.09% C: -25.82%

vaccine breast positive cancer study
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
Published: 2023-03-27 (Crawled : 14:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 9.43% C: 6.44%

vaccine breast presentation cancer meeting trial
Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 9.54% C: 8.51%

patent vaccine breast technology cancer
Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
Published: 2022-12-08 (Crawled : 14:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 1.84% C: -5.33%

vaccine breast trial cancer
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Published: 2022-11-08 (Crawled : 14:20) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -1.5% H: 2.67% C: -1.15%

vaccine breast symposium trial presentation cancer
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 10.38% C: 9.62%

vaccine breast trial cancer phase 2b
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
Published: 2022-07-21 (Crawled : 13:20) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: -1.49% H: 12.12% C: 10.0%

patent vaccine technology cancer
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
Published: 2022-06-21 (Crawled : 13:20) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 2.25% H: 0.0% C: 0.0%

research vaccine technology cancer publication ovarian cancer
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-28 (Crawled : 13:20) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 4.12% H: 2.52% C: -2.16%

vaccine trial presentation cancer breast cancer
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
Published: 2022-01-25 (Crawled : 14:30) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 3.96% C: 1.32%

patent ovarian cancer bioscience cancer vaccine
Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 2.58% H: 0.0% C: 0.0%

cancer vaccine breast cancer
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology
Published: 2021-08-18 (Crawled : 13:15) - biospace.com/
ANIX | $3.18 3.58% 0.97% 790 twitter stocktwits trandingview |
Health Technology
| | O: 3.47% H: 7.18% C: 5.26%

cancer vaccine patent technology ovarian cancer bioscience
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

MTH | $154.69 -2.21% 12.68% 450K twitter stocktwits trandingview |
Consumer Durables

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services

ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing

IHT P | $1.3712 0.82% 6.48% 0 twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.